Steven W. Lefkowitz - 02 Apr 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Steven W. Lefkowitz
Issuer symbol
CRMD
Transactions as of
02 Apr 2025
Net transactions value
+$80,600
Form type
4
Filing time
03 Apr 2025, 16:30:05 UTC
Previous filing
22 Jan 2025
Next filing
10 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $80,600 +20,000 +20% $4.03 120,498 02 Apr 2025 Direct F1
holding CRMD Common Stock 30,152 02 Apr 2025 Wade Capital Corporation Money Purchase Plan F2
holding CRMD Common Stock 2,000 02 Apr 2025 Reporting Person's Wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -20,000 -100% $0.000000 0 02 Apr 2025 Common Stock 20,000 $4.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired stock through the exercise of options granted on 02/22/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.
F2 The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).
F3 These stock options, representing a right to purchase 20,000 shares of Common Stock, were granted on 02/22/2022. These stock options are fully vested.